AHR Stock Analysis: Buy, Sell, or Hold?
AHR - American Healthcare REIT, Inc.
$46.93
-0.20 (-0.42%)
▼
5d:
-2.37%
30d:
-10.16%
90d:
-2.13%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Get Alerted When AHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AHR appears deeply undervalued. Market expects -7.9% annual earnings decline despite 306% recent earnings growth. Contrarian opportunity at discount to historical valuation.
✅ BUY SIGNAL: AHR appears deeply undervalued. Market expects -7.9% annual earnings decline despite 306% recent earnings growth. Contrarian opportunity at discount to historical valuation.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$44.95
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$27.91
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AHR is currently trading at $46.93, which is considered oversold relative to its 30-day fair value range of $49.12 to $53.31. From a valuation perspective, the stock is trading at a discount (Forward PE: 50.8) compared to its historical average (65.1). Remarkably, the market is currently pricing in an annual earnings decline of 7.9% over the next few years. This pessimistic expectation contrasts with the company's recent 306.2% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is currently testing key support at $47.09. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $58.08 (+23.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AHR is in a strong uptrend. The price is currently testing key support at $47.09. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $58.08 (+23.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$49.12 -
$53.31
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.8% below Wall St target ($58.08)
Fair Price Analysis
30-Day Fair Range
$49.12 -
$53.31
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$47.09
Resistance Level
$53.37
Current Trend
Strong Uptrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
50.83
Wall Street Target
$58.08
(+23.8%)
Revenue Growth (YoY)
11.9%
Earnings Growth (YoY)
306.2%
Profit Margin
3.1%
Valuation Discount vs History
-7.9% cheaper
PE vs Historical
50.8 vs 65.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.9%
(market-implied from PE analysis)
1-Year Target
$43.22
(-8%)
2-Year Target
$39.81
(-15%)
3-Year Target
$36.66
(-22%)
3-Yr Target (if PE normalizes)
(PE: 51→65)
$46.96
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 50.8, Growth: 30.0%)
$103.21
(+120%)
Base:
(SPY PE: 22.4, Growth: 30.0%)
$45.38
(-3%)
Bear:
(PE: 19.0, Growth: 30.0%)
$38.57
(-18%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (62x PE), but valuation improves significantly next year (51x PE) as earnings recover.
Forward PE: 61.73 | Forward EPS (Implied): $0.78
Bull Case
$58.04
(+21%)
Analyst growth 15.0%, PE expands to 64.8
Base Case
$48.07
(0%)
Market implied 0.0%, PE stable at 61.7
Bear Case
$36.77
(-24%)
Severe decline -15.0%, PE contracts to 55.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 50.8 to 65.1
Stabilization Target:
$60.11
(+28.1%)
PE Expansion Potential:
+28.1%
Share & Embed Analysis
Last updated: March 31, 2026 3:16 AM ET
Data refreshes hourly during market hours. Next update: 4:16 AM
Data refreshes hourly during market hours. Next update: 4:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Jeffrey T Hanson
SELL
19208 shares
2025-12-23
Jeffrey T Hanson
SELL
35570 shares
2025-12-22
Mark E Foster
SELL
1500 shares
2025-11-11
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$92 | 61 BUY |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$229 | 53 HOLD |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$20 | 54 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$15 | 57 HOLD |
|
CTRE
CareTrust REIT Inc. |
STRONG BUY
9 analysts |
$44 | 60 HOLD |
